Biosimilar medicines

Michael Ward, Ross McKinnon

    Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

    Abstract

    Biological medicines are proteins and polysaccharides derived from living organisms. Vaccines, immunoglobulins, interferons, erythropoiesis-stimulating agents and low-molecular-weight heparins are examples of biological medicines. The traditional understanding of 'generics' cannot be directly applied to biological medicines. Off-patent biological medicines produced by alternative manufacturers are not generic medicines or biogenerics, but are 'similar biological medicinal products', otherwise known as biosimilars.
    Original languageEnglish
    Title of host publicationAustralian pharmaceutical formulary handbook
    Subtitle of host publicationthe everyday guide to pharmacy practice
    EditorsLloyd Sansom
    Place of PublicationCanberra
    PublisherPharmaceutical Society of Australia
    ChapterB
    Pages94-96
    Number of pages3
    Edition23rd
    ISBN (Print)9780987455048
    Publication statusPublished - 2015

    Keywords

    • Biosimilars
    • Biological medicines
    • Drug therapy

    Fingerprint Dive into the research topics of 'Biosimilar medicines'. Together they form a unique fingerprint.

    Cite this